Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events

BACKGROUND: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, asso...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Circ Heart Fail
Glavni autori: Wieselthaler, Georg M., Klein, Liviu, Cheung, Anson W., Danter, Matthew R., Strueber, Martin, Mahr, Claudius, Mokadam, Nahush A., Maltais, Simon, McGee, Edwin C.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2021
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059760/
https://ncbi.nlm.nih.gov/pubmed/33866829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items